Better Science, Better Health
“Better Science, Better Health” was created by Vital Transformation to advance healthcare by connecting stakeholders worldwide and translating complex research, regulation, and evidence into clear, accessible knowledge.
“Better Science, Better Health” is an educational initiative created by Vital Transformation to support learning and collaboration across the healthcare community. Its purpose is to help all stakeholders in healthcare—such as patients, healthcare professionals, regulators, researchers, and industry—better understand the health care scene, new ways of developing and approving medicines.
Better Science, Better Health explains regulatory approaches, new types of scientific evidence, and the use of real-world data. It will also help make the research produced by the Vital Transformation team (www.vitaltransformation.com) more accessible to a broad audience.
What are we up to?
Check it out
VT went to Glasgow
At ISPOR Europe 2025 in Glasgow, Duane and Ben recorded a series of Vital Health Podcast conversations on how Europe can deliver faster, evidence-based access to innovative therapies while keeping health systems sustainable.
All good and well, but want to see how we build our booth?
Video & pics …
VT was part of Trials@Home
The Trials@Home consortium explored the opportunities of moving clinical trials from the traditional clinic setting to the participant’s immediate surroundings.
Petra and Gwen were the VT forces in the project and what did they do?
Video …
Interesting stuff
Blog: What is the Inflation Reduction Act (IRA) and what are the effects?
Inflation Reduction Act (IRA) medicine pricing rules are reshaping therapy development and financing, with ripple effects for patient access. Read More …
FDA vs EMA Approval: Why Decisions Can Differ
A drug approved by the US Food and Drug Administration (FDA) may not be approved by the European Medicines Agency (EMA) due to differences in regulatory frameworks, evidence expectations, and risk tolerance — not because one decision is “right” or “wrong”.
Read More …
Vital Health Podcast
Listen to the Vital Health Podcast
Visit our youtube channel to view all of our videos.
Archive
Unifying Generations: Building the Pathway to Intergenerational Solidarity
21 June 2022, Brussels
Demographic changes and medical advances mean that, for the first time, four generations share a longer lifespan together. This societal evolution requires a revolutionary change to the way age and generations are perceived.
As we emerge from the past two years, questions arise around how we can better support cohesion between generations and intergenerational unity moving forward in a time of global uncertainty.
A panel of experts in the field of intergenerational solidarity, demographic change, and healthy ageing sat down together to discuss key insights gathered in a new report Unifying Generations: Building the Pathway to Intergenerational Solidarity, while addressing the new emerging pathway that needs to be built to highlight the value the third generation brings to society.
Early Bird: Ever closer Union for cancer patients? How to facilitate access to clinical trials across borders
7 February 2022, 8.30-9.00 CET
Participating in a clinical trial for a new medicine can be the ultimate hope for cancer patients. However, access to clinical trials across borders often remains challenging, even in the European Union: patients are vulnerable and often face high costs, language and cultural challenges, and patients and clinicians must deal with additional legal uncertainties.
The good news is that there is broad consensus amongst European institutions, researchers and their networks, and cancer patients that enabling patients’ access to clinical trials across borders is important. Also, and at just one year old, Europe’s Beating Cancer Plan presents an opportunity to facilitate cross-country clinical trials.
Considering the political will and momentum in Europe, what are practical challenges for patients and researchers to enable more cross-border participation? How can Europe’s Beating Cancer Plan facilitate better legislative, administrative, and regulatory frameworks? What are best practices that can help to find solutions fast enough for patients in need of access to treatments now?
Webinar: Climate and Health – why should policymakers and the public be concerned?
23 November
With the global temperatures on the rise and increasing climate instability, what will be the impact on health? How can society best respond now to future challenges that both address the economic realities of climate change and anticipate any demands that may be placed upon public health systems which are already under severe strain due to demographic shifts and aging populations.
Natural experiments of the impact of enforced rapid reduction in economic activity and reduced pollution are being seen in response to the COVID-19 pandemic. Topics to be considered in the webinar include impacts of planned efforts to limit climate change on financial health and thus funding for healthcare; increasing need for emergency support for floods and associated epidemics; health effects of forced migration; and climate change, pollution and health. Reducing global warming via less pollution would reduce risks of communicable diseases and non- communicable diseases, including cancers. What evidence on health benefits of limiting climate change would lead to a change in policy?
Webinar: Equity and Outcomes, Ensuring Fair Access to Healthcare
28 September 2021, 4pm UK
Life expectancy is generally on the increase, including healthy life expectancy. New treatments that have greatly improved the chance of survival following the diagnosis of life-threatening diseases.
However, comparisons of survival rates reveal striking differences among countries for cancers, cardiovascular disorders and other serious non-communicable and communicable diseases, even between countries with a similar GDP. What are the reasons for these differences and, more importantly, what are the best ways to address them?
The aim of the session is to raise awareness among health policy makers, clinical and biotechnology, health professionals, academics and interested public and patients about gaps and needs for equity in health outcomes and fair access to healthcare.